# Carbon Ion Radiotherapy in Frail Patients With Pancreatic Cancer

Source: https://onco.cc/trials/nct07257523/  
OnCo record `nct07257523` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial in pancreatic cancer, run by Yonsei University, now recruiting.

## Summary

Carbon Ion Radiotherapy in Frail Patients With Pancreatic Cancer is a phase 2, interventional study registered as NCT07257523 by Yonsei University, with a registry enrolment figure of 33 participants, started 2025-09-23 and due to reach its primary completion in 2027-07. Interventions recorded: Carbon Ion Radiotherapy. Conditions listed: Pancreatic Neoplasm. Primary outcome: Overall survival in frail patients with pancreatic cancer receiving carbon ion radiotherapy. Pancreatic eligibility wording from the registry: "\- Histologically confirmed pancreatic cancer without distant metastasis". Sites: South Korea. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT07257523
- Phase: 2
- Setting: Carbon Ion Radiotherapy in Frail Patients With Pancreatic Cancer: A Prospective Phase II Study
- Sponsor: Yonsei University
- Enrolled: 33

## Sources

- ClinicalTrials.gov NCT07257523: https://clinicaltrials.gov/study/NCT07257523

## Connected records

- cancers: [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/)
- technologies: [IMRT / IGRT (modern external beam)](https://onco.cc/technologies/imrt-igrt/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07257523.json